Chapter
Licensed
Unlicensed
Requires Authentication
Metabolism of Amphetamines
-
G. Pfeiffer
You are currently not able to access this content.
You are currently not able to access this content.
Chapters in this book
- Frontmatter I
- Preface V
- Contents VII
-
I. Basic Research
- Pharmacology of Amphetamines 3
- Labelling of Amphetamines with ¹²³I 11
- Receptors for Amphetamines 19
- Metabolism of Amphetamines 25
- New Amphetamine Derivatives 35
- Biokinetics of N-Isopropyl,p-123I-Iodoamphetamine in the Human 45
- ²°¹ TI-Diethyldithiocarbamate as an Alternative for ¹²³I-Amphetamine in Brain Imaging with SPECT 51
- Development of a Lipophilic 99mTc Complex Useful for Brain Perfusion Evaluation with Conventional SPECT Imaging Equipment 59
- Potential New Approaches for the Development of Brain Imaging Agents for Single-Photon Applications 71
- Performance of a Multidetector Brain Scanner Compared to a Rotating Gamma Camera System for the Same Scan Task 85
- IMP SPECTwith the Pinhole Collimator 97
-
II. Clinical Results
- Clinical Relevance of N-Isopropyl-(¹²³I)p-Iodoamphetamine (IMP) SPECT Brain Imaging 109
- Regional iodoamphetamine (¹²³I-IMP) Uptake (SPECT) and Regional Cerebral Blood Flow (¹³³Xe-DSPECT) 127
- Regional Quantification of SPECT-Studies of the Brain with N-Isopropyl-[¹²³I]p-Iodo-Amphetamine (IMP) 139
- Brain SPECT with ¹²³I-Labelled Amphetamine Derivatives in Epilepsy and Migraine 149
- IMP-SPECTand Amino Acid-PET in Brain Tumors 157
- 123I-p-iodo-Isopropyl Amphetamine for Brain Tumor Diagnosis 167
- An Early Appraisal of Clinical Results of ¹²³I HIPDMSPECT Studies 171
- List of contributors 179
- Author’s index 181
- Subject index 183
Chapters in this book
- Frontmatter I
- Preface V
- Contents VII
-
I. Basic Research
- Pharmacology of Amphetamines 3
- Labelling of Amphetamines with ¹²³I 11
- Receptors for Amphetamines 19
- Metabolism of Amphetamines 25
- New Amphetamine Derivatives 35
- Biokinetics of N-Isopropyl,p-123I-Iodoamphetamine in the Human 45
- ²°¹ TI-Diethyldithiocarbamate as an Alternative for ¹²³I-Amphetamine in Brain Imaging with SPECT 51
- Development of a Lipophilic 99mTc Complex Useful for Brain Perfusion Evaluation with Conventional SPECT Imaging Equipment 59
- Potential New Approaches for the Development of Brain Imaging Agents for Single-Photon Applications 71
- Performance of a Multidetector Brain Scanner Compared to a Rotating Gamma Camera System for the Same Scan Task 85
- IMP SPECTwith the Pinhole Collimator 97
-
II. Clinical Results
- Clinical Relevance of N-Isopropyl-(¹²³I)p-Iodoamphetamine (IMP) SPECT Brain Imaging 109
- Regional iodoamphetamine (¹²³I-IMP) Uptake (SPECT) and Regional Cerebral Blood Flow (¹³³Xe-DSPECT) 127
- Regional Quantification of SPECT-Studies of the Brain with N-Isopropyl-[¹²³I]p-Iodo-Amphetamine (IMP) 139
- Brain SPECT with ¹²³I-Labelled Amphetamine Derivatives in Epilepsy and Migraine 149
- IMP-SPECTand Amino Acid-PET in Brain Tumors 157
- 123I-p-iodo-Isopropyl Amphetamine for Brain Tumor Diagnosis 167
- An Early Appraisal of Clinical Results of ¹²³I HIPDMSPECT Studies 171
- List of contributors 179
- Author’s index 181
- Subject index 183